PubMed HealthSearch

Biomedical subjects

J Neiman

Publications and source records attributed to J Neiman.

27 records · Page 2Linked to original sources

Elimination kinetics of ethanol and acetaldehyde in healthy men during the calcium carbimide-alcohol flush reaction.

In a crossover design experiment, we investigated the elimination kinetics of ethanol and acetaldehyde during the calcium carbimide (CC)-alcohol flush reaction. Ten healthy men swallowed a tablet of calcium carbimide (50 mg) or placebo and about 2 hours later drank 0.25 g/kg ethanol within 5 min. The pulmonary blood concentrations of ethanol and acetaldehyde were estimated indirectly by analysis of end-expired alveolar air. The onset of facial flushing and associated cardiovascular response coincided with the peak concentrations of ethanol and acetaldehyde in blood. The speed of absorption of alcohol was faster in subjects treated with CC. A smaller volume of distribution of ethanol was evident after pretreatment with CC; 0.636 L/kg compared with 0.675 L/kg after placebo. The rate of elimination of ethanol from blood was about 5% slower in subjects given the CC tablet. The disposition kinetics of acetaldehyde were markedly different when aldehyde dehydrogenase (ALDH) was inhibited. The maximum blood-levels of acetaldehyde ranged from 40-242 microM compared with 1.7-6.5 microM in the placebo control experiments. The elimination half-life of acetaldehyde after CC treatment ranged from 18-31 min. Our results do not support a significant role of acetaldehyde in regulating in-vivo metabolism of ethanol in humans.

Acetaldehyde

Platelet function during acetaldehyde intoxication in healthy male volunteers.

ADP-induced platelet aggregation, associated thromboxane B2 (TXB2) formation and urinary excretion of the prostacyclin metabolite 2,3-dinor-6-keto prostaglandin F1 alpha (PGI2-M) were studied in healthy male volunteers after ingestion of ethanol (0.25 g per kg of body weight) and calcium carbimide (50 mg). Platelet aggregation was suppressed (p less than 0.05) by ethanol, but no changes were observed in platelet TXB2 formation. Ingestion of calcium carbimide caused a significant elevation in blood acetaldehyde (p less than 0.001) and ethanol (p less than 0.05) levels, but acetaldehyde did not influence platelet aggregation or TXB2 formation. However, calcium carbimide per se elevated TXB2 production (p less than 0.05). Ethanol and acetaldehyde appeared not to have any significant effect on urinary excretion of PGI2-M.

6-Ketoprostaglandin F1 alpha

Combined effect of a small dose of ethanol and 36 hr fasting on blood-glucose response, breath-acetone profiles and platelet function in healthy men.

Six healthy men drank 0.25 g/kg ethanol after an overnight fast (12 hr) and the same dose was consumed again after a further 24 hr fasting. The concentration of ethanol and acetone in end-expired alveolar air was determined at 15 min intervals for 3 hr after ethanol intake by a gas chromatographic method. Before drinking and 30 and 90 min thereafter blood samples were taken for determination of glucose, ADP-induced platelet aggregation and associated thromboxane (TXB2) formation. The breath-ethanol time course was virtually identical after 12 and 36 hr fasting and the peak concentration occurred 30 min after drinking. Fasting for 36 hr caused a 20-fold increase in breath-acetone levels. Under these conditions, i.e. after 12 and 36 hr fasting, the hypoglycemic response to ethanol intake was 10 and 25%, while the antiketogenic response was 38 and 16%, respectively. ADP-induced platelet aggregation and associated TXB2 formation showed wide interindividual variations, but no definite effects of ethanol, hypoglycemia or metabolic acidosis were observed. Platelet function was not significantly influenced by ingestion of a small dose of ethanol after prolonged fasting.

Acetone

Hyperbaric oxygen in chronic progressive multiple sclerosis: visual evoked potentials and clinical effects.

The effects of hyperbaric oxygen at a pressure of two atmospheres absolute were studied in a group of patients with chronic progressive multiple sclerosis. A slight but statistically insignificant shortening of the visual evoked potential latencies was seen after treatment with hyperbaric oxygen as compared with placebo treatment. The treatment did not appreciably halt the progression of the disease and deferioration occurred more often among the patients in the treatment group than in the control group.

Adult

Planning process a powerful tool.

Although business and industry have been involved with the planning process for some time, hospitals have only recently realized the powerful tool that the process represents.

American Hospital Association